Posted BY: Teresa | NwoReport
Pharmaceutical giant Pfizer is developing a vaccine specifically for pregnant women that will immunize an unborn baby while still in the womb.
Pfizer claims that infants will be protected against the respiratory syncytial virus (RSV) after birth.
RSV effects 97% of children by age 2. It has a 99.9976% survival rate. There is no need for a vaccine for it.— Jordan Schachtel @ dossier.substack.com (@JordanSchachtel) November 2, 2022
Yet Pfizer has decided that RSV can serve as a revenue stream, & they've created a maternal "vaccine" for it.
They will submit it to the FDA for approval by EOY.
Pfizer announced Tuesday that its maternal RSV vaccine, given during pregnancy, protected infants from developing severe symptoms during the first six months after birth — a critical window of vulnerability. https://t.co/cwrQcnyHvs— The Washington Post (@washingtonpost) November 1, 2022
Huge news for the babies!— Dr. Neuro 🏳️🌈 🦠💉💪 (@Neurofourier) November 1, 2022
Pfizer’s bivalent RSV vaccine has demonstrated amazing efficacy (81.8% against severe lower respiratory illness). This was well tolerated and with results meeting criteria, Pfizer has stopped enrollment and will plan to submit by end of 2022! pic.twitter.com/dObCKEjBJT